Pediatric patients with traditionally “high-risk” reaction histories should not be excluded from penicillin allergy evaluation, according to new research that will be presented at the 2022 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI).

Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AQST-109, the first and only orally delivered epinephrine-based product candidate for the emergency treatment of allergic reactions, including anaphylaxis.

Kids With Food Allergies (KFA) is sharing this press release from the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting to bring you the latest research news. This year's meeting was held Feb. 25 - 28. [PRESS RELEASE] Phase 1 Trial Shows Epinephrine Can Meet Therapeutic Thresholds When Administered Sublingually Treatment shows promise as a viable alternative for the treatment of anaphylaxis, according to new research from the 2022 AAAAI Annual Meeting.

Epinephrine is a life-saving medicine used to treat a severe allergic reaction called anaphylaxis [anna-fih-LACK-sis] . People with food allergies need to carry epinephrine with them at all times. If you or your child have food allergies, your doctor will probably write a prescription for an epinephrine device. Your doctor will prescribe an epinephrine auto-injector that is easy to use. There are several types of epinephrine devices available. Each device has its own unique set of...

New predictors of safety for peanut oral immunotherapy (OIT) in preschoolers will help physicians develop a personalized approach to OIT safety, according to a recent study that will be presented at the 2022 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI).

Updates as of Jan. 28, 2022: We have updated this blog post to reflect the most recent recommendations from the Asthma and Allergy Foundation of America (AAFA) and the Centers for Disease Control and Prevention (CDC). As more information becomes available, we will continue to update our community. The COVID-19 vaccine is an important part of reducing the spread of the coronavirus , ending the pandemic, and protecting ourselves and other people. It can reduce your chance of severe COVID-19,...

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth.

Do you know a teen with food allergies? One of our partners is conducting an online survey on food allergy experiences in teens. TAKE THE SURVEY Who: Our partner is looking for teens with food allergies age 13 to 18. Your teen’s answers and identity will be completely anonymous throughout the survey process and will not be given to the survey’s sponsors or marketed or sold in any way. They will never be asked for their name or personal information while taking the survey. What: Your teen’s...

Some people in the United States have expressed concern over getting one of the three currently available COVID-19 vaccines due to fear of an allergic reaction to the ingredients. Two new studies being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting show most people who think they will have an allergic reaction, or who believe they have had an allergic response to the first vaccine, can safely be fully vaccinated.

It’s well known that 9 of 10 Americans who believe they are allergic to penicillin are not allergic. It’s also known that broad spectrum antibiotics are not as effective as penicillin and their use can increase antibiotic resistance. A new study showed the majority of pregnant women with a penicillin allergy label who were tested were not allergic and could tolerate penicillin during labor.

Allergists and pediatricians have recommended since 2017 that parents start to introduce peanut product around the time their child begins solid foods to prevent peanut allergy. A new study being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals that early egg introduction is associated with decreased egg allergy.

In 2017, the National Institute of Allergy and Infectious Diseases (NIAID) released guidelines to help parents introduce peanut products to their infants to prevent peanut allergy. A new study being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals that although 58% of those surveyed reported their primary care physician (PCP) discussed early peanut introduction, only 40% of the parents said they received a recommendation.

It is safe for ALL people (6 months and older) with an egg allergy to get a flu vaccine every year. This is true no matter how severe your egg allergy was in the past. This includes people who have had anaphylaxis (a severe allergic reaction) to egg. Five organizations recommend that people get the flu vaccine every year, even if they have an egg allergy. These organizations are: Asthma and Allergy Foundation of America (AAFA) Centers for Disease Control and Prevention (CDC) American Academy...

If a child is allergic to tree nuts, are they able to touch acorns? Should they avoid them to be safe? Can they cause allergic reactions?

Update for Oct. 1, 2021: Did you miss the live stream of the PFDD meeting on food allergy? You can watch the recording . You can still share your experiences living with and managing food allergy. Send in your comments by Oct. 9, 2021. We will include your comments in the upcoming food allergy “Voice of the Patient Report.” We will send this report to FDA representatives. By sharing your story, you can help influence the future of treatments for food allergies. SUBMIT YOUR COMMENTS The...

COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles to treat immune disorders (CNPs), today announced the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for evaluation of COUR's CNP-201 in a proof-of-concept (Phase 1 / 2) study in people who are allergic to peanuts.

As regulators, the FDA recognizes they have an important task ahead of them that will require them to act expeditiously while undertaking an extremely meticulous and thoughtful review once we receive requests to authorize a COVID-19 vaccine for emergency use or submissions for approval of a COVID-19 vaccine for this population.

Aimmune Therapeutics, Inc., a Nestlé Health Science company developing and commercializing pharmaceutical therapies to prevent, manage, and treat food and metabolic-related diseases, today announced the publication of a longitudinal analysis that explored the safety, efficacy and food allergy-related quality of life of long-term treatment with PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp, previously known as investigational agent AR101] in patients with peanut allergy.

Even if a child with a food allergy has had it all their life, each growth stage comes with its own concerns and challenges. In the “Spotlight: Transition to Adulthood,” we found that the period when a child moves into adulthood comes with a greater risk when food allergies are involved. It also causes a lot of anxiety for their parents.

Update: If you missed the webinar, we added the video below. We also included some resources on additional information discussed in the webinar, as well as answers to several questions we received. Kids With Food Allergies (KFA) hosted a webinar on May 13, 2021, on the latest research on food allergy anaphylaxis in infants and toddlers. The webinar was presented by: Michael Pistiner, MD, MMSc, pediatric allergist at MassGeneral Hospital for Children in Boston, Massachusetts Melanie Carver,...